1. Preliminary program 2^nd International Beijing Cancer

   Report Pages: A4 - A5

2. Physicochemical and pharmacokinetic parameters of seven lipophilic chlorambucil esters designed for brain penetration

   • Nigel H. Greig
   • Shigeru Genka
   • Stanley I. Rapoport

   Original Articles Pages: 311 - 319

3. Pharmacokinetics of chlorambucil-tertiary butyl ester, a lipophilic chlorambucil derivative that achieves and maintains high concentrations in brain

   • Nigel H. Greig
   • Eileen M. Daly
   • Stanley I. Rapoport

   Original Articles Pages: 320 - 325

4. Protective effects of fructose-1,6-diphosphate on acute and chronic doxorubicin cardiotoxicity in rats

   • Romano Danesi
   • Nunzia Bernardini
   • Mario Del Tacca

   Original Articles Pages: 326 - 332

5. Cardiotoxicity and antitumor activity of a copper(II)-doxorubicin chelate

   • Elena Monti
   • Luisa Paracchini
   • Rosanna Supino

   Original Articles Pages: 333 - 336

6. In vitro chemosensitivity testing of Fotemustine (S 10036), a new antitumor nitrosourea

   • J. L. Fischel
   • P. Formento
   • G. Milano

   Original Articles Pages: 337 - 341

7. Effect of whole-body hyperthermia on hepatic cytochrome P450

   • A. J. Neville
   • G. Singh

   Original Articles Pages: 342 - 344

8. Phase I study of Brequinar sodium (NSC 368390) in patients with solid malignancies

   • Gilberto Schwartsmann
   • Pierre Dodion
   • Herbert M. Pinedo

   Original Articles Pages: 345 - 351

9. Relationship between the pharmacokinetics and toxicity of mitozolomide

   • D. J. Kerr
   • J. A. Slack
   • S. B. Kaye

   Original Articles Pages: 352 - 354

10. Efficacy and safety of high-dose cisplatin and cyclophosphamide with glutathione protection in the treatment of bulky advanced epithelial ovarian cancer

    • Francesco Di Re
    • Silvia Bohm
    • Franco Zunino

    Original Articles Pages: 355 - 360

11. Clinical pharmacodynamics of continuous-infusion etoposide

    • Antonius A. Miller
    • Clinton F. Stewart
    • Elizabeth A. Tolley

    Original Articles Pages: 361 - 366

12. Etoposide, carboplatin, cyclophosphamide and vincristine in previously untreated patients with small-cell lung cancer

    • James F. Bishop
    • Richard Kefford
    • Alan Zimet

    Original Articles Pages: 367 - 370

13. False-positive ketone tests: a bedside measure of urinary mesna

    • Marshall P. Goren
    • Charles B. Pratt

    Original Articles Pages: 371 - 372

14. High-dose cisplatin in disseminated melanoma: a comparison of two schedules

    • Joanne E. Mortimer
    • Susan Schulman
    • Gary Goodman

    Original Articles Pages: 373 - 376

15. The 5-HT₃ antagonist, BRL 43694, does not compromise the efficacy of cisplatin in tumour-bearing mice

    • Phyllis M. Goddard
    • Mervyn Jones
    • Kenneth R. Harrap

    Short Communication Pages: 377 - 379

16. Mitomycin, ifosfamide and cisplatin in non-small-cell lung cancer

    • David C. Currie
    • David W. Miles
    • Robert L. Souhami

    Short Communication Pages: 380 - 381

17. Complete remission of brain metastases of ovarian cancer following high-dose carboplatin: a case report and pharmacokinetic study

    • L. Thomas Vlasveld
    • Jos H. Beynen
    • Sjoerd Rodenhuis

    Short Communication Pages: 382 - 383

18. Methotrexate sensitivity in Down's syndrome: a hypothesis

    • P. M. Ueland
    • H. Refsum
    • B. Christensen

    Letter to the Editors Pages: 384 - 386

19. The case of Vepesid overdosage in a patient with Hodgkin's disease

    • Marek Pawlicki
    • Beata Zuchowska-Vogelgesang
    • Elzbieta Sliz

    Letter to the Editors Pages: 387 - 387

20. Meeting announcements

    Announcement Pages: 388 - 388